Literature DB >> 27555526

Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages.

Federico Carbone1, Nathalie Satta2, Fabienne Burger3, Aline Roth3, Sébastien Lenglet3, Sabrina Pagano2, Pierre Lescuyer2, Maria Bertolotto4, Giovanni Spinella5, Bianca Pane5, Domenico Palombo5, Aldo Pende6, Franco Dallegri6, François Mach3, Nicolas Vuilleumier2, Fabrizio Montecucco6.   

Abstract

The role of Vitamin D system in cardiovascular diseases remains controversial. Here, we investigated whether intraplaque levels of vitamin D receptor (VDR) predicted major adverse cardiovascular events (MACEs) at 18month-follow-up and correlated with macrophage subsets in 164 patients undergoing endarterectomy for carotid stenosis. In human carotid plaque portions upstream and downstream the blood flow, VDR, lipid, collagen, as well as macrophage subsets were determined. Human primary monocytes were then differentiated in vitro to M1 and M2 macrophages and treated with 1,25(OH)2D3. Intraplaque VDR positively correlated with total and M1 macrophages. According to the result of ROC curve analysis, downstream portions of plaques having high VDR expression were characterized by increased M1 macrophages. Kaplan-Meier analysis showed that the risk of MACEs was greater in patients having low downstream VDR levels (8.2% vs. 1.3%; p=0.005). Cox proportional hazard regression analyses confirmed that MACE risk decreased with increasing downstream VDR (adjusted HR 0.78 [95% CI 0.62-0.98]; p=0.032). In vitro, VDR expression was prevalent in M1, but not M2. Incubation of M1 macrophages with 1,25(OH)2D3, increased VDR expression and suppressed toll-like receptor 4 expression. These results suggest that low intraplaque VDR expression predict MACEs in patients with carotid stenosis potentially involving M1 macrophages.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Macrophage; Major adverse cardiovascular events; Vitamin D; Vitamin D receptor

Mesh:

Substances:

Year:  2016        PMID: 27555526     DOI: 10.1016/j.vph.2016.08.004

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  4 in total

Review 1.  Role of Vitamin D in Cardiovascular Diseases.

Authors:  Vikrant Rai; Devendra K Agrawal
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

2.  Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine.

Authors:  Mohan Satish; Palanikumar Gunasekar; Juan A Asensio; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2020-08-01       Impact factor: 3.396

Review 3.  Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.

Authors:  Luca Liberale; Stefano Ministrini; Federico Carbone; Giovanni G Camici; Fabrizio Montecucco
Journal:  Basic Res Cardiol       Date:  2021-03-26       Impact factor: 17.165

Review 4.  Vitamin D: Not Just Bone Metabolism but a Key Player in Cardiovascular Diseases.

Authors:  Marcello Izzo; Albino Carrizzo; Carmine Izzo; Enrico Cappello; Domenico Cecere; Michele Ciccarelli; Patrizia Iannece; Antonio Damato; Carmine Vecchione; Francesco Pompeo
Journal:  Life (Basel)       Date:  2021-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.